FDA supports Starpharma's fast-track potential for DEPยฎ SN38 in treating tough ovarian cancer cases. A key step towards Phase 2/3 trials.
๐ https://t.co/n2V5rRUSQD
Algorae Pharmaceuticals ($1AI) takes AI-driven drug discovery to the next level with 24 new oncology targets! Preclinical studies coming soon.
Exciting times for biotech! #ASX#AI